Introduction: Epidemiological evidence strongly suggests that steroid hormones are implicated in the pathogenesis of ovarian cancer. Estrogen
Introduction
Ovarian cancer causes more than 140,000 deaths worldwide every year and is the most lethal gynaecological malignancy in developed countries [1] . In the USA, this neoplasm ranks second among gynaecological cancers, yet it is by far the most lethal one, accounting for more than 15,000 deaths annually [2, 3] . Ovarian cancer is often known as "the silent killer," its early detection is difficult because the ovaries are deep within the pelvis and initial symptoms are often ambiguous. The cancer goes undiagnosed until after the disease is far advanced and has spread throughout the abdomen or to distant organs. Nearly 75% of cases are diagnosed at an advanced stage, despite great efforts to develop reliable screening and prevention strategies [4, 5] . Majority of patients with ovarian carcinoma eventually succumb to disease due to development of treatment resistance. The introduction of cisplatinbased chemotherapy was initially thought to show improvement in the survival of patients with ovarian cancer, the percentage of recurrent disease is still high even in those patients who achieve a complete response to chemotherapy, so that more than 80% of patients with advanced stage of disease in Africa die within 5 years [2, 6, 7] . More effective treatment regimens and better early detection tools must be developed to improve morbidity and reduce mortality in ovarian cancer patients [3, 7, 8] . This has led to the development of "targeted" oncologic therapies that might ultimately be more effective and less toxic. Steroid hormone receptors expression in epithelial ovarian cancers has been proposed to have therapeutic and prognostic relevance, as is the case in breast cancer [7] . At present, the prognostic characterisation of ovarian cancer patients, based on clinicopathological parameters such as stage, histology, grade and residual tumour after surgery, seems to be inadequate, since patients with similar clinicopathological characteristics often experience different clinical outcome.
Therefore, the identification of biological factors related to tumour aggressiveness could be relevant in order to identify patients with different prognosis and chance to respond to chemotherapy, thus allowing the selection, at the time of initial diagnosis, of high risk patients needing more aggressive therapy or alternative treatment and a closer follow-up [3, 8] .
Among the biological parameters proposed as possible prognostic factors in ovarian cancer, much attention has been focused on endocrine factors and especially on steroid hormones and their receptors (estrogen and progesterone receptors). Epithelial tumours are most frequently associated with nulliparity, early menarche, late age at menopause and a long estimated number of years of ovulation [9, 10] . Different theories have been proposed as causal relationship between ovarian stimulation and neoplasia including Fathalla's incessant ovulation hypothesis which was initially thought to explain the pathogenesis of the tumour [11] . Recently however studies have shown that ovarian carcinomas arise via two main separate pathways, the high grade serous tumours are now known to arise from the fallopian tube fimbrial precursor lesions implanted on the ovarian surface [12] [13] [14] . Low grade tumours such as endometrioid carcinomas are believed to arise from areas of endometriosis [12] [13] [14] . Steroid hormones, primarily oestrogen and progesterone have been implicated in ovarian carcinogenesis. 
Results
The age range of patients from which the surgical specimens were obtained was from 16 years to 82 years with a mean age of 52.2 ± 12.6 years. The peak age of occurrence of epithelial ovarian cancers was in the fifth decade of life. There was only one case of epithelial ovarian cancer seen in the first two decades of life. Serous carcinomas was the most common histological subtype and was seen in 63 (70.0%) cases, followed by mucinous carcinoma, which accounted for 24 (26.7%)cases, There were 2 (2.2%) endometrioid carcinomas and only 1(1.1%) case of malignant Brenner tumour (Table 1 ). The poorly differentiated (grade 3) serous carcinomas were more commonly seen while the reverse is the case in mucinous carcinomas with grade 1 tumours being more common (Table 2 ). ER and PR are more expressed (35% and 53% respectively) in grade 3 serous carcinoma compared with mucinous carcinoma which has highest PR expression (18%) in grade 2 tumours (Table 2) . A slight majority of Forty-seven (52.2%) cases of epithelial ovarian cancer were at advanced FIGO stage (III/IV) and while forty-three (47.8%) cases were at early FIGO stage (I/II).
Nineteen (21.1%) cases were well-differentiated (grade 1), 34 (37.8%) were moderately differentiated (grade 2) while 37 cases The majority of cases of serous carcinoma and mucinous carcinoma were negative for ER and PR (69.8% and 58.7% respectively). On the average, significantly fewer carcinomas were negative for ER.
No association was found between PR expression and histological subtypes (p = 0.650) ( Table 3) .
Discussion
The expression rates of ER and PR in this study is similar to what There was no significant association between ER expression and FIGO stage in our study similar to what was reported by Kauppila et al [37] . This however contrasts with the report of Burges et al where a significant expression of ER was observed in advanced FIGO stage [35] . Kauppila et al also reported an association between ER expression, age and grade similar to what was reported in this study [37] . 
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